| Literature DB >> 34495527 |
Soo-Yeon Yang1, Seung A Chae1, Won Yeong Bang1, Minjee Lee1, O-Hyun Ban1,2, Soo-Jung Kim3, Young Hoon Jung4, Jungwoo Yang5.
Abstract
This study investigated the anti-inflammatory activity of Lactiplantibacillus plantarum IDCC 3501 isolated from kimchi (Korean fermented food) and its safety. When lipopolysaccharide (LPS)-induced RAW 264.7 macrophages were treated with cell-free supernatant from L. plantarum IDCC 3501, the mRNA expression level of inflammatory markers (i.e., TNF-α, IL-1β, and IL-6) was significantly reduced. In addition, the decreased cell viability by LPS was recovered and NO production in LPS-induced cell was also decreased. For the safety assessment, the genes responsible for antibiotic resistance and virulence were not detected from the genome analysis of this strain. Consistent with this, minimal inhibitory concentrations against various antibiotics, biogenic amines, and D-lactate production, as well as enzymatic and hemolysis activities, indicated that L. plantarum IDCC 3501 did not produce any harmful compounds during fermentation. Furthermore, no acute toxicity and mortality were observed in a murine mouse model. Based on our findings, L. plantarum IDCC 3501 is safe and beneficial for human consumption.Entities:
Keywords: Anti-inflammatory; Lactic acid bacteria; Lactiplantibacillus plantarum; Probiotics; Safety evaluation
Mesh:
Substances:
Year: 2021 PMID: 34495527 PMCID: PMC8578256 DOI: 10.1007/s42770-021-00603-2
Source DB: PubMed Journal: Braz J Microbiol ISSN: 1517-8382 Impact factor: 2.214